HM Payson & Co’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-500
| Closed | -$20.4K | – | 1182 |
|
|
2024
Q2 | $20.4K | Hold |
500
| – | – | ﹤0.01% | 755 |
|
|
2024
Q1 | $21.1K | Hold |
500
| – | – | ﹤0.01% | 739 |
|
|
2023
Q4 | $21.2K | Hold |
500
| – | – | ﹤0.01% | 730 |
|
|
2023
Q3 | $10.9K | Hold |
500
| – | – | ﹤0.01% | 809 |
|
|
2023
Q2 | $15.9K | Hold |
500
| – | – | ﹤0.01% | 754 |
|
|
2023
Q1 | $12.2K | Hold |
500
| – | – | ﹤0.01% | 776 |
|
|
2022
Q4 | $15.8K | Hold |
500
| – | – | ﹤0.01% | 709 |
|
|
2022
Q3 | $14K | Hold |
500
| – | – | ﹤0.01% | 757 |
|
|
2022
Q2 | $13K | Hold |
500
| – | – | ﹤0.01% | 786 |
|
|
2022
Q1 | $18K | Buy |
+500
| New | +$18K | ﹤0.01% | 770 |
|